Our GLP-3 (RUO) is a high-purity, lyophilized peptide engineered to target three distinct metabolic pathways. Unlike standard agonists, this “triple threat” sequence activates GLP-1, GIP, and Glucagon receptors simultaneously, offering researchers a comprehensive tool for studying advanced glucose regulation and caloric expenditure.
In stock
This peptide has not been reviewed or approved by the FDA, EMA, MHRA, or any regulatory authority. No claims are made regarding clinical safety, therapeutic value, or disease-related effects. All information pertains exclusively to controlled laboratory experimentation and not clinical use.
By purchasing this product, the buyer agrees that:
They are a qualified researcher or institution
They will follow all lawful handling, storage, and laboratory protocols
All sales are final and supplied without clinical warranty
This compound is intended solely for scientific research and experimental data generation.
Every vial is linked to its own certificate of analysis — download the exact document for this batch before you order.
This batch's certificate of analysis is shown below. Click to view it full size.
Orders placed before 2 PM EST ship the same business days. Most US orders arrive within 1–3 business days with tracking. All shipments include temperature indicators to confirm cold-chain integrity on arrival.
BPC-157-10MG (RUO)
MOTS-C-10MG (RUO)
Repair and Restore Starter Research Kit
SLU-PP-332-(100/Tablets) (RUO)
